Published in Lancet on January 25, 1975
Specific immunoglobulins in infants with the congenital rubella syndrome. J Hyg (Lond) (1976) 1.83
Persistence of immunoglobulin G and immunoglobulin M antibodies after postnatal rubella infection determined by solid-phase radioimmunoassay. J Clin Microbiol (1978) 1.35
Specific immunoglobulin responses after varicella and herpes zoster. J Hyg (Lond) (1979) 1.15
Use of enzyme immunoassays and the latex agglutination test to measure the temporal appearance of immunoglobulin G and M antibodies after natural infection or immunization with rubella virus. J Clin Microbiol (1983) 1.05
IgA antibody response in acute rubella determined by solid-phase radioimmunoassay. J Hyg (Lond) (1979) 1.03
Epstein-Barr virus-specific serum immunoglobulin A as an acute-phase antibody in infectious mononucleosis. J Clin Microbiol (1979) 0.98
BK antibody and virus-specific IgM responses in renal transplant recipients, patients with malignant disease, and healthy people. Br Med J (1977) 0.96
Rubella-specific immune complexes after congenital infection and vaccination. Infect Immun (1982) 0.93
Specific IgM responses after rubella vaccination; potential application following inadvertent vaccination during pregnancy. Br Med J (1977) 0.93
Clinical evaluation of the sensitivity and specificity of a commercially available enzyme immunoassay for detection of rubella virus-specific immunoglobulin M. J Clin Microbiol (1984) 0.87
Detection of rubella-specific serum IgG and IgA and nasopharyngeal IgA responses using a radioactive single radial immunodiffusion technique. Clin Exp Immunol (1975) 0.85
Detection of immunoglobulin G and A antibodies to rubella virus in urine and antibody responses to vaccine-induced infection. Clin Diagn Lab Immunol (1998) 0.84
Humoral immune response after primary rubella virus infection and after vaccination. Clin Vaccine Immunol (2007) 0.84
Can we prevent an increase in the incidence of congenital rubella syndrome in the next decade? Can Med Assoc J (1981) 0.82
Significance of rubella virus infection in juvenile chronic polyarthritis. Ann Rheum Dis (1977) 0.79
The administration of drugs and vaccines by the intranasal route. Br J Clin Pharmacol (1976) 0.78
Laboratory diagnosis and clinical significance of rubella in children with cancer. Epidemiol Infect (1989) 0.75
Development of a rapid and convenient method for determination of rubella virus-specific immunoglobulin G avidity. Clin Vaccine Immunol (2007) 0.75
A report--chronic fatigue syndrome: guidelines for research. J R Soc Med (1991) 7.70
HIV seroprevalence among women attending antenatal clinics in London. Lancet (1992) 4.46
Serum IgM and IgG responses in postnatally acquired rubella. Lancet (1969) 4.16
A serological method for demonstrating recent infection by rubella virus. Br Med J (1967) 4.07
Hepatitis A. BMJ (1991) 3.77
Detection and differentiation of picornaviruses in clinical samples following genomic amplification. J Gen Virol (1990) 2.77
Clinical trial with inactivated hepatitis A vaccine and recommendations for its use. BMJ (1992) 2.76
Liver disease among homosexual males. Lancet (1979) 2.74
Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ (1989) 2.48
Rapid diagnosis of enterovirus infection by magnetic bead extraction and polymerase chain reaction detection of enterovirus RNA in clinical specimens. J Clin Microbiol (1993) 2.45
Serological assessment of rubella during pregnancy. Br Med J (1970) 2.37
In-vitro detection of human rotaviruses. Lancet (1975) 2.28
Routine use of mu-antibody-capture ELISA for the serological diagnosis of Coxsackie B virus infections. J Med Virol (1986) 2.21
Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet (1985) 2.08
Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis (1983) 2.07
Hepatitis B infections after gynaecological surgery. Lancet (1989) 1.99
Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. Lancet (1983) 1.94
Asymptomatic endemic rotavirus infections in the newborn. Lancet (1978) 1.93
Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health (1989) 1.92
Letter: Rotavirus infections in a maternity unit. Lancet (1975) 1.92
Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet (1981) 1.86
The effect of trypsin on the growth of rotavirus. J Gen Virol (1978) 1.86
Hepatitis B vaccine boosting among young healthy adults. Lancet (1994) 1.85
Medical students' risk of infection with bloodborne viruses at home and abroad: questionnaire survey. BMJ (1999) 1.79
Voluntary, named testing for HIV in a community based antenatal clinic: a pilot study. BMJ (1995) 1.78
Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma. Lancet (1972) 1.73
Rotavirus infections in a maternity unit. Arch Dis Child (1976) 1.71
Detection of enterovirus RNA in clinical samples by nested polymerase chain reaction for rapid diagnosis of enterovirus infection. J Virol Methods (1994) 1.67
Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed) (1982) 1.66
Letter: Rubella-specific IgM and a new inhibitor. Br Med J (1974) 1.66
A case of Lassa fever: experience at St Thomas's Hospital. Br Med J (Clin Res Ed) (1982) 1.59
Clinical evaluation of the turkey-erythrocyte passive-haemagglutination test for hepatitis-B surface antigen. Lancet (1974) 1.59
Hepatitis B vaccine uptake among surgeons at a London teaching hospital: how well are we doing? Ann R Coll Surg Engl (1996) 1.58
Rubella immunity by four different techniques: results of challenge studies. J Med Virol (1980) 1.58
Antibodies to fastidious faecal adenoviruses (species 40 and 41) in sera from children. J Med Virol (1983) 1.57
Studies on rubella virus strain variation by kinetic haemagglutination-inhibition tests. J Gen Virol (1970) 1.56
Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases. Lancet (1980) 1.54
Herpes genitalis; clinical and virological studies. Br J Vener Dis (1967) 1.50
PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol (1995) 1.47
Quantitation of HIV: correlation with clinical, virological, and immunological status. J Med Virol (1991) 1.40
Letter: Polio vaccination for travellers. Br Med J (1975) 1.39
Cancer associated human papillomaviruses: perinatal transmission and persistence. Br J Obstet Gynaecol (1994) 1.38
Measles must go and with it rubella. Br Med J (Clin Res Ed) (1987) 1.38
Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS (1999) 1.33
Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by non-invasive differential sugar permeation. Eur J Clin Invest (1986) 1.33
Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods (1992) 1.32
Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic. Lancet (1990) 1.30
Persistence of rubella antibody 8-18 years after vaccination. Br Med J (Clin Res Ed) (1984) 1.30
Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge. J Infect Dis (1980) 1.30
Maternal rubella at St Thomas' Hospital in 1978 and 1986: support for augmenting the rubella vaccination programme. Lancet (1987) 1.26
New Japanese rubella vaccine: comparative trials. Br Med J (1974) 1.26
Hepatitis A antibodies in London blood donors, medical students, and patients. Lancet (1980) 1.24
Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J Infect Dis (1999) 1.23
A comparison of Rubazyme-M and MACRIA for the detection of rubella-specific IgM. J Virol Methods (1984) 1.21
Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes. Biochem Pharmacol (1987) 1.20
Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection. Lancet (1989) 1.19
Cord blood and breast-milk antibodies in neonatal rotavirus infection. Br Med J (1980) 1.19
Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees. J Infect Dis (1985) 1.18
Willingness of homosexual and bisexual men in London to be screened for human immunodeficiency virus. Br Med J (Clin Res Ed) (1986) 1.16
Patients with suspected Lassa fever in London during 1984: problems in their management at St Thomas's Hospital. Br Med J (Clin Res Ed) (1985) 1.14
A comparison of RK-13, vervet monkey kidney and patas monkey kidney cell cultures for the isolation of rubella virus. J Hyg (Lond) (1967) 1.14
Viral infections of Toronto children during 1965: II. Measles encephalitis and other complications. Can Med Assoc J (1966) 1.12
Perinatal infection and persistence of human papillomavirus types 16 and 18 in infants. J Med Virol (1995) 1.12
Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes. J Gen Virol (1989) 1.11
Maternal rubella and the rubella syndrome in infants. Epidemiologic, clinical, and virologic observations. Am J Dis Child (1965) 1.11
Rubella vaccines. Lancet (1979) 1.10
Herpes simplex virus detection by ELISA: effect of enzyme amplification, nature of lesion sampled and specimen treatment. J Med Virol (1986) 1.09
Letter: Diagnosis of rubella. Br Med J (1974) 1.08
Persistence of rubella antibodies after vaccination: detection after experimental challenge. Rev Infect Dis (1985) 1.08
Serological studies in infectious mononucleosis. Br Med J (1969) 1.03
Rubella syndrome and thrombocytopenic purpura in newborn infants. Clinical and virologic observations. N Engl J Med (1965) 1.03
Failure of intranasally administered 4', 6-dichloroflavan to protect against rhinovirus infection in man. Arch Virol (1987) 1.03
Rubella serology by solid-phase radioimmunoassay: its potential for screening programmes. Clin Exp Immunol (1978) 1.03
Towards vaccines against human papillomavirus type-16 genital infections. Vaccine (1993) 1.02
Rubella vaccination: remaining problems. Br Med J (Clin Res Ed) (1982) 1.02
Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol (1995) 1.01
A randomised controlled study of intravenous acyclovir (Zovirax) against placebo in adults with chickenpox. J Infect (1983) 1.01